Ge. Salvi et al., MONOCYTIC TNF-ALPHA SECRETION PATTERNS IN IDDM PATIENTS WITH PERIODONTAL-DISEASES, Journal of clinical periodontology, 24(1), 1997, pp. 8-16
The aim of the present study was to identify whether monocytic TNF alp
ha secretion patterns could serve as a potential phenotypic discrimina
tor for periodontal disease susceptibility within insulin-dependent di
abetes mellitus (IDDM) patients. In 32 IDDM individuals the lipopolysa
ccharide (LPS) stimulated monocytic TNF alpha secretion dose-response
characteristics were analyzed and related to two different periodontal
status categories. Diabetics were divided into group A (gingivitis or
mild periodontal disease) and group B (moderate to severe periodontal
disease). In addition, 17 non-diabetic individuals with various degre
es of periodontal disease served as control patients. Diabetics as a g
roup had a significantly higher monocytic TNF alpha production in resp
onse to increasing Porphyromonas gingivalis A 7436 lipopolysaccharide
concentrations (0, 0.003, 0.03, 0.3 and 3.0 mu g/ml) as compared to no
n-diabetic patients with gingivitis or adult periodontitis (p<0.05). A
significant difference in the dose response was also noted in the lev
el of TNF alpha secreted as a function of P. gingivitis LPS concentrat
ions between group A and B diabetics, as determined by two-way repeate
d measurements ANOVA (p<0.05). Furthermore, there was no significant d
ifference in the mean HbA(1C) between the two diabetic groups, and the
TNF alpha level was not significantly associated with the HbA(1C) lev
el within diabetic patients. These data suggest that the diabetic stat
e results in an upregulated monocytic TNF alpha secretion phenotype (4
.6-fold increase) which, in the presence of Gramnegative bacterial cha
llenge, is associated with a more severe periodontal disease expressio
n. In addition, approximately 40% (10 of 24) IDDM periodontitis patien
ts in group B demonstrated a 62-fold elevation in TNF alpha secretion
relative to non-diabetic gingivitis or periodontitis patients and a 13
.5-fold increase relative to IDDM group A (gingivitis or mild periodon
titis) patients.